Mutant IDH1 and Seizures in Patients With Glioma

Neurology - United States
doi 10.1212/wnl.0000000000003911
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Seizures in Patients With Glioma Treated With Phenytoin and Levetiracetam

Journal of Neurosurgery
SurgeryNeurology
2010English

Allosteric Mutant IDH1 Inhibitors Reveal Mechanisms for IDH1 Mutant and Isoform Selectivity

Structure
Structural BiologyMolecular Biology
2017English

Clinical Management of Seizures in Patients With Low-Grade Glioma

Seminars in Radiation Oncology
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2015English

Mutant IDH1 Cooperates With ATRX Loss to Drive the Alternative Lengthening of Telomere (ALT) Phenotype in Glioma

Cancer Research
Cancer ResearchOncology
2018English

Vemurafenib Has Activity in Patients With BRAFV600-Mutant Glioma

Cancer Discovery
Oncology
2018English

Combination Treatment of an IDH1 Inhibitor With Chemotherapy in IDH1 Mutant Acute Myeloid Leukemia

Annals of Hematology
MedicineHematology
2020English

Differential Distribution of CCDC26 Glioma-Risk Alleles in Myeloid Malignancies With Mutant IDH1 Compared With Their IDH2R140-mutated or IDH-unmutated Counterparts

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

IDH1 Mutation Diminishes Aggressive Phenotype in Glioma Stem Cells

International Journal of Oncology
Cancer ResearchOncology
2017English

IDH1 Gene Mutations: A New Paradigm in Glioma Prognosis and Therapy?

Oncologist
Cancer ResearchMedicineOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy